Sweet Success for Chocolate Touch DCB in Femoropopliteal Disease

The paclitaxel-coated balloon with a quirky design and confectionery name achieved better patency outcomes and noninferiority for safety compared with another DCB with a long track record.

Related Keywords

New York ,United States ,Ann Arbor ,Michigan ,New Zealand ,Washington ,Boston ,Massachusetts ,New Haven ,Connecticut ,Yale New Haven Hospital ,Myers Squibb ,Celonova Biosciences ,Roxana Mehran ,Insel Gruppe ,Case Western Reserve School Of Medicine ,Astrazeneca Pharmaceuticals ,Novartis ,University Of Michigan ,Abiomed ,Idorsia Pharmaceuticals ,Bayer Healthcare Pharmaceuticals ,Yale School Of Medicine ,American College Of Cardiology ,Boston Scientific ,Philips ,Icahn School Of Medicine At Mount Sinai ,Research Institute ,Medtronic ,Abbott Laboratories ,Trireme Medical ,Chocolate Touch Study ,American College ,Investigator Mehdi ,Case Western Reserve School ,Chocolate Touch ,Yale School ,Icahn School ,Mount Sinai ,Abbott Vascular ,Inquis Medical ,Med Research Institute ,Alleviant Medical ,Concept Medical ,Element Science ,Applied Therapeutics ,Elixir Medical ,Peripheral Vascular Disease ,Implanted Device Cardiology ,Peripheral Angioplasty ,